TCL Archive “Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says September 25, 1998
TCL Archive In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin April 22, 1977
TCL Archive Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit. October 26, 2001
TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013